Correlation between lipoprotein(a) serum concentration and severity of coronary artery stenosis in an Iranian population according to Gensini score

Clinical Biochemistry

Volumn 41, Issue 3, 2008, Pages 117-120

  Boroumand, Mohammad Ali ^a   Rekabi, Vahab ^a   Davoodi, Gholamreza ^a   Amirzadegan, Alireza ^a   Saadat, Soheil ^a   Abbasi, Seyed Hesameddin ^a   Hamidian, Reza ^a   Poorgholi, Leila ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary atherosclerosis; Coronary stenosis; Lipoprotein(a); Severity

Indexed keywords

LIPOPROTEIN;

ADULT; ANGIOGRAPHY; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; IRAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE;

ADULT; AGED; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IRAN; LIPOPROTEIN(A); MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POPULATION GROUPS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 38649120069     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.10.004     Document Type: Article

References (27)

1. Heart disease and stroke statistics: 2007 update. American heart association, accessed at www.americanheart.org on 07/02/2007.
2. Mansur A.P., Favarato D., Souza M.F., et al. Trends in death from circulatory diseases in Brazil between 1979 and 1996. Arq Bras Cardiol 76 (2001) 497-510
3. Kuller L.H. Ethnics differences in atherosclerosis, current cardiovascular and lipid metabolism diseases. Curr Opin Lipidol 915 (2004) 109-113
4. Schoen F.J., and Cotran R.S. Heart diseases. In: Cotran R.S., Kumar V., and Collins T. (Eds). Robbins pathologic basis of diseases. 6th ed. (2001), WB Saunders, Philadelphia 506-510
5. Bachoric P.S., and Dende M.A. Lipids and dyslipoproteinemia. In: Henry J.B. (Ed). Davidson clinical diagnosis and management by laboratory methods. 20th ed. (2001), WB Saunders, Philadelphia 25-50.
6. Ariyo A.A., Thach C., and Tracy R. LP(a) lipoprotein, vascular disease and mortality in the elderly. N Engl J Med 349 (2003) 2108-2115
7. Sotiriou S.N., Orlova V.V., Al-Fakhri N., et al. Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin. FASEB J 20 (2006) 559-561
8. Koschinsky M.L. Lipoprotein(a) and atherosclerosis: new perspectives on the mechanism of action of an enigmatic lipoprotein. Curr Atheroscler Rep 7 (2005) 389-395
9. Tsironis L.D., Katsouras C.S., Lourida E.S., et al. Reduced PAF-acetylhydrolase activity associated with LP(a) in patients with coronary artery disease. Atherosclerosis 177 (2004) 193-201.
10. Frolkis J.P. Should one routinely screen for lipoprotein (a)?. Clevelan Clin J Med 66 8 (1999) 465-466
11. Lubodovic D.D., Toseska Trajkovska K.N., Alabakovska S.B., Todorova B.B., and Jovanova S. The role of LP(a) levels and apoprotein(a) phenotype in the develpement of atherosclerosis in patients with coronary artery disease. Atheroscler Suppl 7 (2006) 70
12. Willeit J., Kiechl S., Staner P., et al. Lipoprotein (a) and asymptomatic carotid artery disease. Stroke 26 (1995) 1582-1587
13. Baldassarre D., Tremoli E., Franceschini G., et al. Plasma lipoprotein (a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke 27 (1996) 1044-1049
14. Jurgens G., Taddi-Peters W., Koltringer P., et al. Lipoprotein (a) serum concentration and apolipoprotein (a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke 26 (1995) 1841-1848
15. Iwamoto T., Fukuda S., Shimizu S., and Takasaki M. Long-term effects of lipoprotein a) on carotid atherosclerosis in elderly Japanese. J Gerontol A Biol Sci Med Sci 59 (2004) 62-67
16. Zenker G., Koltringer P., Bone G., et al. Lipoprotein (a) as a strong indicator for cerebrovascular disease. Stroke 17 (1986) 942-945
17. Ridker P.M., Hennekens C.H., and Stampfer M.J. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 270 (1993) 195-199
18. Gurewich V., and Mittelman M. Lipoprotein(a) in coronary heart disease. Is it a risk factor after all?. JAMA (1994) 1025-1026
19. Rahmani M., Raiszadeh F., Allahverdani S., Kiaii S., Navab M., and Aziziz F. Coronary artery disease is associated with the radio of lipoprotein A-l/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects. Atherosclerosis 162 (2002) 381-389
20. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51 3 (1983) 606
21. Anuuard E., Boffa M.B., Koschinsky M.L., and Berglund L. Lipoprotein(a): a unique risk factor for cardiovascular disease. Clin Lab Med. 26 (2006) 751-772
22. Katsouras C.S., Karabina S.A., Tambakina A.P., et al. Serum LP(a) concentration and apolipoprotein(a) isoforms: correlation with the severity of clinical presentation in patients with coronary heart disease. J Cardiovasc Risk 8 (2001) 311-317
23. Klein G., Brugger P., Kullich W., Marth E., and Kostner G.M. Lipoprotein LP(a) as a risk factor for heart infarct-a family history. Wien Med Wochenschr 134 (1984) 403-408
24. Sano R., Fujino A., Shimazu H., et al. Serum LP(a) lipoprotein concentration of Japanese patients with coronary heart disease. Tohoku J Exp Med 162 (1990) 261-267
25. Averna M.R., Barbagallo C.M., Ocello S., et al. LP(a) levels in patients undergoing aorto-coronary bypass surgery. Eur Heart J 13 (1992) 1405-1409
26. Imhof A., Rothenbacher D., Khuseyinova N., et al. Plasma lipoprotein LP(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease. Eur J Cardiovasc Prev Rehabil 10 (2003) 362-370
27. Heinimann K., Stahelin H.B., Perrig-Chiello P., et al. Lipoprotein (a) and plasma lipids in 429 elderly and very old subjects: significance as risk factor, effect of nutrition and life style. Schweiz Med WochenSchr 126 (1996) 114